Cepheid has announced the European release of the Xpert™ MRSA (Methicillin-resistant Staphylococcus aureus) test for clinical diagnostic use on the GeneXpert ® System. The MRSA test was released as a ...

The Xpert MRSA/SA BC test will be used for examining Methicillin-resistant Staphylococcus aureus (:MRSA) and Staphylococcus aureus (SA, typically methicillin susceptible) in blood culture bottles ...

Co announces it received clearance from the FDA to market its Xpert M.R.S.A test, which runs on the GeneXpert System, for the rapid detection of Methicillin-resistant Staphylococcus aureus. "Currently ...

Cepheid CPHD recently launched its Xpert MRSA NxG assay in the commercial markets overseas, after the test won the CE-IVD status under the European Directive on In Vitro Diagnostic Medical Devices.

SUNNYVALE, Calif., Sept. 29 Cepheid(Nasdaq: CPHD) today announced it has received clearance from the U.S. Food &Drug Administration (FDA) to market its Xpert(TM) MRSA/SA Skin and Soft TissueInfection ...

The next-gen MRSA infection control test runs on Cepheid's GeneXpert systems. Image: Cepheid () Molecular diagnostics player Cepheid scored an FDA OK for its next-gen MRSA infection control test, ...

July 3, 2010 — A test to detect methicillin-resistant Staphylococcus aureus (MRSA) and S aureus (SA) has been recalled by the manufacturer based on an increasing number of complaints about false ...

Cepheid ( CPHD) recently gained the U.S. Food and Drug Administration (FDA) approval for the commercialization of its Xpert MRSA/SA Blood Culture (BC) test. The test, which runs on the company's ...